← Open Payments lookup

NPI 1639591423: Open Payments

NPI 1639591423. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$952 in 51 payments from 12 companies in 2025. Trend: 2023 $1,096 · 2024 $1,000 · 2025 $952

Food & beverage: $952
CompanyPaymentsAmount
SCPHARMACEUTICALS INC.9$181
Merck Sharp & Dohme LLC10$149
Novartis Pharmaceuticals Corporation11$136
Medtronic, Inc.1$101
E.R. Squibb & Sons, L.L.C.6$94
PFIZER INC.5$94
Alnylam Pharmaceuticals Inc.2$59
Bayer Healthcare Pharmaceuticals Inc.2$56
AstraZeneca Pharmaceuticals LP2$29
Philips North America LLC1$20

Products named: FUROSCIX, LEQVIO, VERQUVO, SYMPLICITY G3, CAMZYOS, AMVUTTRA, ELIQUIS, Kerendia.